SMARCB1 and head and neck neoplasm: The 2017 edition of the WHO classification of head and neck tumours recognizes NUT carcinoma as a separate entity related to the group of midline carcinomas that generally are highly aggressive, while with regard to SMARCB1-deficient carcinoma it remains unclear wether it constitutes a distinct entity1.